| Dr Hava Tillipman Ladinsky, MD | |
|
844 Washington Rd Ste 201, Westminster, MD 21157-6796 | |
| (410) 857-7900 | |
| (410) 857-1150 |
| Full Name | Dr Hava Tillipman Ladinsky |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 17 Years |
| Location | 844 Washington Rd Ste 201, Westminster, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902008527 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | D0070570 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sinai Hospital Of Baltimore | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Asthma And Allergy Center Llc | 7719909639 | 40 |
| Asthma And Allergy Center Llc | 7719909639 | 40 |
News Archive
Almost three quarters of patients with extensive burns die of the consequences of a severe infection. In the current edition of Deutsches Ärzteblatt International, Timo A. Spanholtz of the Cologne-Merheim Burn Center and his coauthors discuss the acute therapy and follow-up care of burn disease.
Arginetix, Inc. today announced it has closed a $10.75 million Series A financing. The company is developing small molecule inhibitors of the enzyme arginase for the treatment of endothelial dysfunction, including pulmonary arterial hypertension, atherosclerosis and asthma.
The G8 nations have "delivered only 61 percent of the increased aid they promised to sub-Saharan Africa by 2010 in their 2005 summit" in Gleneagles, Scotland, an annual report by ONE shows, Reuters reports.
Today, UK charity Action on Hearing Loss announces a major investment to fund a new project to develop medicines to treat age-related hearing loss and noise-induced hearing loss at BioTrinity 2016 – Europe's Leading Investment and Biopartnering Conference.
› Verified 4 days ago
| Entity Name | Asthma & Allergy Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912089335 PECOS PAC ID: 7719909639 Enrollment ID: O20170706001064 |
News Archive
Almost three quarters of patients with extensive burns die of the consequences of a severe infection. In the current edition of Deutsches Ärzteblatt International, Timo A. Spanholtz of the Cologne-Merheim Burn Center and his coauthors discuss the acute therapy and follow-up care of burn disease.
Arginetix, Inc. today announced it has closed a $10.75 million Series A financing. The company is developing small molecule inhibitors of the enzyme arginase for the treatment of endothelial dysfunction, including pulmonary arterial hypertension, atherosclerosis and asthma.
The G8 nations have "delivered only 61 percent of the increased aid they promised to sub-Saharan Africa by 2010 in their 2005 summit" in Gleneagles, Scotland, an annual report by ONE shows, Reuters reports.
Today, UK charity Action on Hearing Loss announces a major investment to fund a new project to develop medicines to treat age-related hearing loss and noise-induced hearing loss at BioTrinity 2016 – Europe's Leading Investment and Biopartnering Conference.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hava Tillipman Ladinsky, MD 844 Washington Rd Ste 201, Westminster, MD 21157-6796 Ph: (410) 857-7900 | Dr Hava Tillipman Ladinsky, MD 844 Washington Rd Ste 201, Westminster, MD 21157-6796 Ph: (410) 857-7900 |
News Archive
Almost three quarters of patients with extensive burns die of the consequences of a severe infection. In the current edition of Deutsches Ärzteblatt International, Timo A. Spanholtz of the Cologne-Merheim Burn Center and his coauthors discuss the acute therapy and follow-up care of burn disease.
Arginetix, Inc. today announced it has closed a $10.75 million Series A financing. The company is developing small molecule inhibitors of the enzyme arginase for the treatment of endothelial dysfunction, including pulmonary arterial hypertension, atherosclerosis and asthma.
The G8 nations have "delivered only 61 percent of the increased aid they promised to sub-Saharan Africa by 2010 in their 2005 summit" in Gleneagles, Scotland, an annual report by ONE shows, Reuters reports.
Today, UK charity Action on Hearing Loss announces a major investment to fund a new project to develop medicines to treat age-related hearing loss and noise-induced hearing loss at BioTrinity 2016 – Europe's Leading Investment and Biopartnering Conference.
› Verified 4 days ago